(株)アールテック・ウエノの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証JQS | 医薬品 | 4573/E15678 | R-TECH UENO, LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2015/11/13 | 日証協 | 7,858株 | -26.5% | 467株 | 0% | 27,796株 | -9.74% | 1,100株 | -26.67% |
| 2015/11/06 | 日証協 | 10,691株 | -1.84% | 0株 | -100% | 30,796株 | -0.99% | 1,500株 | -21.05% |
| 2015/10/30 | 日証協 | 10,891株 | +3.4% | 500株 | -62.49% | 31,104株 | +1.63% | 1,900株 | +35.71% |
| 2015/10/23 | 日証協 | 10,533株 | -41.81% | 1,333株 | -66.67% | 30,604株 | +7.37% | 1,400株 | -90.85% |
| 2015/10/16 | 日証協 | 18,100株 | -64.99% | 4,000株 | -87.54% | 28,504株 | -51.11% | 15,300株 | -54.19% |
| 2015/10/09 | 日証協 | 51,700株 | -47.08% | 32,100株 | +435% | 58,304株 | -34.35% | 33,400株 | +279.46% |
| 2015/10/02 | 日証協 | 97,700株 | -48.5% | 6,000株 | 0% | 88,804株 | -48.49% | 8,802株 | 0% |
| 2015/09/25 | 日証協 | 189,700株 | -0.84% | 0株 | 0.00% | 172,404株 | -48.64% | 0株 | 0.00% |
| 2015/09/18 | 日証協 | 191,300株 | 0% | 17,300株 | +1230.77% | 335,704株 | -1.5% | 2,000株 | -98.69% |
| 2015/09/11 | 日証協 | 191,300株 | -13.63% | 1,300株 | -98.35% | 340,804株 | +23.74% | 152,100株 | +95.5% |
| 2015/09/04 | 日証協 | 221,500株 | +26.86% | 78,600株 | +28.43% | 275,414株 | -43.48% | 77,800株 | -56% |
| 2015/08/28 | 日証協 | 174,600株 | -0.11% | 61,200株 | +217.1% | 487,304株 | +25.92% | 176,810株 | +533.11% |
| 2015/08/21 | 日証協 | 174,800株 | -11.4% | 19,300株 | +98.97% | 386,994株 | +3.95% | 27,927株 | +23.03% |
| 2015/08/14 | 日証協 | 197,300株 | +0.2% | 9,700株 | +64.41% | 372,277株 | -0.67% | 22,700株 | +931.82% |
| 2015/08/07 | 日証協 | 196,900株 | +0.36% | 5,900株 | -84.83% | 374,777株 | +0.46% | 2,200株 | -92.74% |
| 2015/07/31 | 日証協 | 196,200株 | -1.6% | 38,900株 | +2331.25% | 373,067株 | +2.36% | 30,320株 | +380.51% |
| 2015/07/24 | 日証協 | 199,400株 | -2.68% | 1,600株 | -84.47% | 364,474株 | -0.41% | 6,310株 | -33.01% |
| 2015/07/17 | 日証協 | 204,900株 | -66.13% | 10,300株 | +53.73% | 365,964株 | -37.78% | 9,420株 | -66.86% |
| 2015/07/10 | 日証協 | 605,000株 | -1.98% | 6,700株 | -91.2% | 588,144株 | -0.84% | 28,427株 | +34.09% |
※株式分割は考慮していませんのでご注意ください。
Page Top